GPC-1 has been proposed to be a biomarker in prostate cancer27, and our recent study shows that GPC-1 displays opposing roles in the progression of prostate cancer by acting as a tumor promoter in 2D models of prostate cancer cell growth, but inhibiting tumor growth in vivo, possibly by interacting with different components of the TME28. Here, GPC1 is linked to neoplasm.